Literature DB >> 16371508

Shiga toxin regulates its entry in a Syk-dependent manner.

Silje Ugland Lauvrak1, Sébastien Wälchli, Tore-Geir Iversen, Hege Holte Slagsvold, Maria Lyngaas Torgersen, Bjørn Spilsberg, Kirsten Sandvig.   

Abstract

Shiga toxin (Stx) is composed of an A-moiety that inhibits protein synthesis after translocation into the cytosol, and a B-moiety that binds to Gb3 at the cell surface and mediates endocytosis of the toxin. After endocytosis, Stx is transported retrogradely to the endoplasmic reticulum, and then the A-fragment enters the cytosol. In this study, we have investigated whether toxin-induced signaling is involved in its entry. Stx was found to activate Syk and induce rapid tyrosine phosphorylation of several proteins, one protein being clathrin heavy chain. Toxin-induced clathrin phosphorylation required Syk activity, and in cells overexpressing Syk, a complex containing clathrin and Syk could be demonstrated. Depletion of Syk by small interfering RNA, expression of a dominant negative Syk mutant (Syk KD), or treatment with the Syk inhibitor piceatannol inhibited not only Stx-induced clathrin phosphorylation but also endocytosis of the toxin. Also, Golgi transport of Stx was inhibited under all these conditions. In conclusion, our data suggest that Stx regulates its entry into target cells.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16371508      PMCID: PMC1382301          DOI: 10.1091/mbc.e05-08-0766

Source DB:  PubMed          Journal:  Mol Biol Cell        ISSN: 1059-1524            Impact factor:   4.138


  57 in total

1.  Endocytosis and signaling: a relationship under development.

Authors:  Marcos González-Gaitán; Harald Stenmark
Journal:  Cell       Date:  2003-11-26       Impact factor: 41.582

2.  Catalytic specificity of phosphotyrosine kinases Blk, Lyn, c-Src and Syk as assessed by phage display.

Authors:  R Schmitz; G Baumann; H Gram
Journal:  J Mol Biol       Date:  1996-08-02       Impact factor: 5.469

3.  Retrograde transport of KDEL-bearing B-fragment of Shiga toxin.

Authors:  L Johannes; D Tenza; C Antony; B Goud
Journal:  J Biol Chem       Date:  1997-08-01       Impact factor: 5.157

Review 4.  Fc receptor biology.

Authors:  M Daëron
Journal:  Annu Rev Immunol       Date:  1997       Impact factor: 28.527

Review 5.  Leukocyte protein tyrosine kinases: potential targets for drug discovery.

Authors:  J B Bolen; J S Brugge
Journal:  Annu Rev Immunol       Date:  1997       Impact factor: 28.527

Review 6.  The Syk/ZAP-70 protein tyrosine kinase connection to antigen receptor signalling processes.

Authors:  N S van Oers; A Weiss
Journal:  Semin Immunol       Date:  1995-08       Impact factor: 11.130

7.  In vivo and in vitro specificity of protein tyrosine kinases for immunoglobulin G receptor (FcgammaRII) phosphorylation.

Authors:  N Bewarder; V Weinrich; P Budde; D Hartmann; H Flaswinkel; M Reth; J Frey
Journal:  Mol Cell Biol       Date:  1996-09       Impact factor: 4.272

8.  Recruitment of epidermal growth factor and transferrin receptors into coated pits in vitro: differing biochemical requirements.

Authors:  C Lamaze; T Baba; T E Redelmeier; S L Schmid
Journal:  Mol Biol Cell       Date:  1993-07       Impact factor: 4.138

9.  Syk protein-tyrosine kinase is regulated by tyrosine-phosphorylated Ig alpha/Ig beta immunoreceptor tyrosine activation motif binding and autophosphorylation.

Authors:  R B Rowley; A L Burkhardt; H G Chao; G R Matsueda; J B Bolen
Journal:  J Biol Chem       Date:  1995-05-12       Impact factor: 5.157

10.  Determinants of the phagocytic signal mediated by the type IIIA Fc gamma receptor, Fc gamma RIIIA: sequence requirements and interaction with protein-tyrosine kinases.

Authors:  J G Park; A D Schreiber
Journal:  Proc Natl Acad Sci U S A       Date:  1995-08-01       Impact factor: 11.205

View more
  35 in total

1.  Cross-linking of glycosphingolipids at the plasma membrane: consequences for intracellular signaling and traffic.

Authors:  Tove Irene Klokk; Simona Kavaliauskiene; Kirsten Sandvig
Journal:  Cell Mol Life Sci       Date:  2015-09-25       Impact factor: 9.261

2.  Shiga toxin facilitates its retrograde transport by modifying microtubule dynamics.

Authors:  Heidi Hehnly; David Sheff; Mark Stamnes
Journal:  Mol Biol Cell       Date:  2006-08-02       Impact factor: 4.138

3.  The Mitogen-activated protein kinase p38 links Shiga Toxin-dependent signaling and trafficking.

Authors:  Sébastien Wälchli; Sigrid S Skånland; Tone F Gregers; Silje U Lauvrak; Maria L Torgersen; Ming Ying; Shun'ichi Kuroda; Andrés Maturana; Kirsten Sandvig
Journal:  Mol Biol Cell       Date:  2007-10-24       Impact factor: 4.138

Review 4.  Molecular mechanisms of clathrin-independent endocytosis.

Authors:  Carsten G Hansen; Benjamin J Nichols
Journal:  J Cell Sci       Date:  2009-06-01       Impact factor: 5.285

5.  Shiga toxin (Stx)1B and Stx2B induce von Willebrand factor secretion from human umbilical vein endothelial cells through different signaling pathways.

Authors:  Fang Liu; Jing Huang; J Evan Sadler
Journal:  Blood       Date:  2011-08-03       Impact factor: 22.113

6.  Retrograde Shiga toxin trafficking is regulated by ARHGAP21 and Cdc42.

Authors:  Heidi Hehnly; Katrina Marie Longhini; Ji-Long Chen; Mark Stamnes
Journal:  Mol Biol Cell       Date:  2009-08-19       Impact factor: 4.138

Review 7.  Shiga toxins--from cell biology to biomedical applications.

Authors:  Ludger Johannes; Winfried Römer
Journal:  Nat Rev Microbiol       Date:  2009-12-21       Impact factor: 60.633

8.  The MAP kinase-activated protein kinase 2 (MK2) contributes to the Shiga toxin-induced inflammatory response.

Authors:  Jose B Saenz; Jinmei Li; David B Haslam
Journal:  Cell Microbiol       Date:  2009-11-27       Impact factor: 3.715

9.  SDPR induces membrane curvature and functions in the formation of caveolae.

Authors:  Carsten G Hansen; Nicholas A Bright; Gillian Howard; Benjamin J Nichols
Journal:  Nat Cell Biol       Date:  2009-06-14       Impact factor: 28.824

10.  Interplay between toxin transport and flotillin localization.

Authors:  Sascha Pust; Anne Berit Dyve; Maria L Torgersen; Bo van Deurs; Kirsten Sandvig
Journal:  PLoS One       Date:  2010-01-22       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.